Published in J Clin Endocrinol Metab on January 01, 2015
Lifestyle Intervention in Preparation for Pregnancy (LIPP) | NCT03146156
Placental Origins of Chronic Disease. Physiol Rev (2016) 0.88
Identification of early transcriptome signatures in placenta exposed to insulin and obesity. Am J Obstet Gynecol (2015) 0.81
Hypoxia: The Force that Drives Chronic Kidney Disease. Clin Med Res (2016) 0.80
Maternal obesity programs mitochondrial and lipid metabolism gene expression in infant umbilical vein endothelial cells. Int J Obes (Lond) (2016) 0.75
Genomic Evidence for Bacterial Determinants Influencing Obesity Development. Int J Environ Res Public Health (2017) 0.75
Maternal and female fetal testosterone levels are associated with maternal age and gestational weight gain. Eur J Endocrinol (2017) 0.75
Effect of maternal obesity on placental lipid metabolism. Endocrinology (2017) 0.75
PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell (1999) 10.08
Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci (2006) 5.15
Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology (1986) 4.89
Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab (1995) 3.34
Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev (2000) 3.14
Anthropometric estimation of neonatal body composition. Am J Obstet Gynecol (1995) 2.82
Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta (2008) 2.67
Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities. Antioxid Redox Signal (2010) 2.11
Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice. Endocrinology (2009) 2.05
Progesterone withdrawal and estrogen activation in human parturition are coordinated by progesterone receptor A expression in the myometrium. J Clin Endocrinol Metab (2002) 1.85
Progesterone synthesis by the human placenta. Placenta (2005) 1.81
Regulation of translocator protein 18 kDa (TSPO) expression in health and disease states. Mol Cell Endocrinol (2010) 1.60
Pregravid obesity associates with increased maternal endotoxemia and metabolic inflammation. Obesity (Silver Spring) (2010) 1.47
Estrogen and androgen receptors: regulators of fuel homeostasis and emerging targets for diabetes and obesity. Trends Endocrinol Metab (2010) 1.41
Estrogen controls lipolysis by up-regulating alpha2A-adrenergic receptors directly in human adipose tissue through the estrogen receptor alpha. Implications for the female fat distribution. J Clin Endocrinol Metab (2004) 1.37
Palmitate-mediated downregulation of peroxisome proliferator-activated receptor-gamma coactivator 1alpha in skeletal muscle cells involves MEK1/2 and nuclear factor-kappaB activation. Diabetes (2006) 1.32
Minireview: the year in review of estrogen regulation of metabolism. Mol Endocrinol (2012) 1.22
Effect of increasing maternal body mass index on oxidative and nitrative stress in the human placenta. Placenta (2008) 1.21
MLN64 exhibits homology with the steroidogenic acute regulatory protein (STAR) and is over-expressed in human breast carcinomas. Int J Cancer (1997) 1.13
Myometrial progesterone responsiveness and the control of human parturition. J Soc Gynecol Investig (2004) 1.11
The 18 kDa translocator protein (TSPO): a new perspective in mitochondrial biology. Curr Mol Med (2012) 1.09
Estrogen Deficiency and the Origin of Obesity during Menopause. Biomed Res Int (2014) 1.08
Structural and functional evolution of the translocator protein (18 kDa). Curr Mol Med (2012) 1.07
Participation of ERalpha and ERbeta in glucose homeostasis in skeletal muscle and white adipose tissue. Am J Physiol Endocrinol Metab (2009) 1.04
Bacterial endotoxin lipopolysaccharide and reactive oxygen species inhibit Leydig cell steroidogenesis via perturbation of mitochondria. Endocrine (2004) 1.04
Kinetic studies of citrate synthase from rat kidney and rat brain. J Biol Chem (1973) 1.02
Progesterone inhibits Toll-like receptor 4-mediated innate immune response in macrophages by suppressing NF-kappaB activation and enhancing SOCS1 expression. Immunol Lett (2009) 0.99
Effect of peroxisome proliferators on Leydig cell peripheral-type benzodiazepine receptor gene expression, hormone-stimulated cholesterol transport, and steroidogenesis: role of the peroxisome proliferator-activator receptor alpha. Endocrinology (2002) 0.96
Enzymes involved in the formation and transformation of steroid hormones in the fetal and placental compartments. J Steroid Biochem Mol Biol (2005) 0.93
The role of 18 kDa mitochondrial translocator protein (TSPO) in programmed cell death, and effects of steroids on TSPO expression. Curr Mol Med (2012) 0.91
The 18-kDa translocator protein, formerly known as the peripheral-type benzodiazepine receptor, confers proapoptotic and antineoplastic effects in a human colorectal cancer cell line. Pharmacogenet Genomics (2008) 0.88
Mitochondrial (dys)function and regulation of macrophage cholesterol efflux. Clin Sci (Lond) (2013) 0.88
The role of progesterone in maternal and fetal medicine. Gynecol Endocrinol (2012) 0.85
MLN64 transport to the late endosome is regulated by binding to 14-3-3 via a non-canonical binding site. PLoS One (2012) 0.80
Translocator protein 18 kDa (TSPO) is regulated in white and brown adipose tissue by obesity. PLoS One (2013) 0.80
Progesterone elicits an inhibitory effect upon LPS-induced innate immune response in pre-labor human amniotic epithelium. Am J Reprod Immunol (2013) 0.79
Misregulated progesterone secretion and impaired pregnancy in Cyp11a1 transgenic mice. Biol Reprod (2013) 0.77
Circulating progesterone and obesity in men. Horm Metab Res (2006) 0.76
The effects of steroid hormones on adipocyte development. Int J Obes (1990) 0.76
A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med (2009) 14.40
Fetuses of obese mothers develop insulin resistance in utero. Diabetes Care (2009) 3.05
The relationship between maternal glycemia and perinatal outcome. Obstet Gynecol (2011) 2.96
Increased neonatal fat mass, not lean body mass, is associated with maternal obesity. Am J Obstet Gynecol (2006) 2.63
The influence of obesity and diabetes on the risk of cesarean delivery. Am J Obstet Gynecol (2004) 1.58
The known and unknown of leptin in pregnancy. Am J Obstet Gynecol (2006) 1.57
Gestational diabetes induces placental genes for chronic stress and inflammatory pathways. Diabetes (2003) 1.56
The human placenta in gestational diabetes mellitus. The insulin and cytokine network. Diabetes Care (2007) 1.54
Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab (2005) 1.52
Pregravid obesity associates with increased maternal endotoxemia and metabolic inflammation. Obesity (Silver Spring) (2010) 1.47
Increased activation of nuclear factor kappaB triggers inflammation and insulin resistance in polycystic ovary syndrome. J Clin Endocrinol Metab (2006) 1.33
Hyperglycemia alters tumor necrosis factor-alpha release from mononuclear cells in women with polycystic ovary syndrome. J Clin Endocrinol Metab (2005) 1.22
Maternal interleukin-6: marker of fetal growth and adiposity. J Soc Gynecol Investig (2006) 1.17
Evidence of proatherogenic inflammation in polycystic ovary syndrome. Metabolism (2009) 1.08
Activation of phospholipase A2 is associated with generation of placental lipid signals and fetal obesity. J Clin Endocrinol Metab (2005) 1.07
Are women with recurrent spontaneous preterm births different from those without such history? Am J Obstet Gynecol (2006) 1.04
Increased death of adipose cells, a path to release cell-free DNA into systemic circulation of obese women. Obesity (Silver Spring) (2012) 1.02
The role of oxidative stress in the pathophysiology of gestational diabetes mellitus. Antioxid Redox Signal (2011) 1.00
Maternal BMI, glucose tolerance, and adverse pregnancy outcomes. Am J Obstet Gynecol (2012) 0.99
Dysregulation of placental endothelial lipase in obese women with gestational diabetes mellitus. Diabetes (2011) 0.99
Evaluation of body composition of large-for-gestational-age infants of women with gestational diabetes mellitus compared with women with normal glucose tolerance levels. Am J Obstet Gynecol (2004) 0.97
Obese reproductive-age women exhibit a proatherogenic inflammatory response during hyperglycemia. Obesity (Silver Spring) (2007) 0.93
Altered tumor necrosis factor alpha release from mononuclear cells of obese reproductive-age women during hyperglycemia. Metabolism (2006) 0.92
Elevated circulating levels of macrophage migration inhibitory factor in polycystic ovary syndrome. Cytokine (2010) 0.89
Molecular phenotype of monocytes at the maternal-fetal interface. Am J Obstet Gynecol (2011) 0.88
Inflammation in response to glucose ingestion is independent of excess abdominal adiposity in normal-weight women with polycystic ovary syndrome. J Clin Endocrinol Metab (2012) 0.88
Mutations in the glucokinase gene of the fetus result in reduced placental weight. Diabetes Care (2008) 0.88
Relationship between 1-hour glucose challenge test results and perinatal outcomes. Obstet Gynecol (2013) 0.87
Molecular inflammation and adipose tissue matrix remodeling precede physiological adaptations to pregnancy. Am J Physiol Endocrinol Metab (2012) 0.87
Fetal male gender and the benefits of treatment of mild gestational diabetes mellitus. Am J Obstet Gynecol (2012) 0.86
In utero gender dimorphism of adiponectin reflects insulin sensitivity and adiposity of the fetus. Obesity (Silver Spring) (2009) 0.86
Leptin: a potential marker of placental insufficiency. Gynecol Obstet Invest (2003) 0.86
Hyperglycemia-induced oxidative stress is independent of excess abdominal adiposity in normal-weight women with polycystic ovary syndrome. Hum Reprod (2012) 0.86
Patterns of adiponectin expression in term pregnancy: impact of obesity. J Clin Endocrinol Metab (2014) 0.84
Glycemic characteristics and neonatal outcomes of women treated for mild gestational diabetes. Obstet Gynecol (2011) 0.82
Glucose ingestion stimulates atherothrombotic inflammation in polycystic ovary syndrome. Am J Physiol Endocrinol Metab (2012) 0.81
Are the metabolic changes of pregnancy reversible in the first year postpartum? Diabetologia (2015) 0.79
Placental growth response to maternal insulin in early pregnancy. J Clin Endocrinol Metab (2015) 0.79
Adiponectin: are measurements clinically useful in pregnancy? Diabetes Care (2013) 0.79
The altered mononuclear cell-derived cytokine response to glucose ingestion is not regulated by excess adiposity in polycystic ovary syndrome. J Clin Endocrinol Metab (2014) 0.77
Customized versus population approach for evaluation of fetal overgrowth. Am J Perinatol (2012) 0.77
The obstetric and neonatal implications of a low value on the 50-g glucose screening test. Am J Perinatol (2012) 0.77
Elevated circulating levels of tissue factor in polycystic ovary syndrome. Clin Appl Thromb Hemost (2012) 0.77
Carpenter-Coustan Compared With National Diabetes Data Group Criteria for Diagnosing Gestational Diabetes. Obstet Gynecol (2016) 0.75
Perinatal outcomes in Hispanic and non-Hispanic white women with mild gestational diabetes. Obstet Gynecol (2012) 0.75
Relationship Between Excessive Gestational Weight Gain and Neonatal Adiposity in Women With Mild Gestational Diabetes Mellitus. Obstet Gynecol (2016) 0.75
Effect of ω-3 supplementation on placental lipid metabolism in overweight and obese women. Am J Clin Nutr (2016) 0.75
Inhibition by adenine dinucleotides of ATP-induced prostacyclin release by bovine aortic endothelial cells. Biochem Pharmacol (2002) 0.75
Pregnancy in a spinal cord-injured bilateral total leg amputee: management and considerations. Am J Obstet Gynecol (2003) 0.75